Prostate Cancer - Results from #220

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. December 13, 2022

PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry. December 13, 2022

European Health Union: Commission Welcomes Adoption of New EU Cancer Screening Recommendations December 12, 2022

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only. December 12, 2022

Safety and Efficacy of CT-Guided Percutaneous Biopsy of Suspicious Subcentimeter Pelvic and Retroperitoneal Lymph Nodes Detected by 11C-Choline PET in Patients With Prostate Cancer. December 12, 2022

Long-Term Outcomes following Active Surveillance of Low-Grade Prostate Cancer: A Population-Based Study Using a Landmark Approach. December 12, 2022

MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving? December 12, 2022

The Experiences and Unmet Supportive Care Needs of Partners of Men Diagnosed With Prostate Cancer: A Meta-aggregation Systematic Review. December 12, 2022

Systematic review of methods used to improve the efficacy of magnetic resonance in early detection of clinically significant prostate cancer. December 9, 2022

Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging. December 9, 2022

Systematic review of self-management programs for prostate cancer patients, a quality of life and self-efficacy meta-analysis. December 9, 2022

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies. December 9, 2022

Adherence With Oral Anticancer Therapies: Clinical Trial versus Real-World Experiences with a Focus on Prostate Cancer. December 9, 2022

Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases. December 8, 2022

Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN study. December 8, 2022

Using PSMA imaging for prognostication in localized and advanced prostate cancer. December 8, 2022

Clinical validation of the Varian Truebeam intra-fraction motion review (IMR) system for prostate treatment guidance. December 8, 2022

Prostate cancer mortality rates in low- and favorable intermediate-risk active surveillance patients: a population-based competing risks analysis. December 8, 2022

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial December 7, 2022

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 December 7, 2022

Page 12 of 1276

email news signup